Does neoadjuvant targeted therapy provide an opportunity for resectable EGFR-mutant lung cancer: a real-world retrospective study

BACKGROUND: Although neoadjuvant chemotherapy could improve survival outcome in resectable non–small cell lung cancer (NSCLC), the efficacy of neoadjuvant targeted therapy is still unclear. METHODS: We retrospectively reviewed clinical records of stage I–IIIA lung adenocarcinoma patients treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Chao, Ma, Yuanyuan, Feng, Qin, Lu, Fangliang, Chi, Yongkun, Wu, Nan, Fang, Jian, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656393/
https://www.ncbi.nlm.nih.gov/pubmed/33209366
http://dx.doi.org/10.21037/jtd-20-1265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656393/
https://www.ncbi.nlm.nih.gov/pubmed/33209366
http://dx.doi.org/10.21037/jtd-20-1265

Ejemplares similares